AI-generated summary
The authors studied 26 participants with moderate to advanced meibomian gland dysfunction who received intense pulsed light treatment combined with gland expression at baseline, Week 2 and Week 6. They report significant improvements in some clinical signs at Week 8 and in symptom scores and tear break-up time at Week 12, with no adverse effects. The study was single-institution, open-label and lacked a control group.
- Participants
- 26
- Who or what was studied
- Adults with chronic dry eye due to moderate to advanced meibomian gland dysfunction
- Limits stated in the abstract
- The study was single-institution, open-label, prospective and had no control group.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on tandfonline.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Dry eye, Inflammation. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.